J. Porter

A phase I study of OSI-461 in combination with mitoxantrone in patients with advanced solid tumors potentially responsive to mitoxantrone

M. Carducci, M. Eisenberger, C. Sweeney, 2010, Cancer Chemotherapy and Pharmacology.

A new scoring system for the Bath Ankylosing Spondylitis Metrology Index (BASMI)

A. Calin, S. Garrett, L. Kennedy, 1995, The Journal of rheumatology.

Which patients with ankylosing spondylitis derive most benefit from an inpatient management program?

A. Calin, S. Garrett, L. Kennedy, 1997, The Journal of rheumatology.

A pharmacokinetic and safety study of intravenous arsenic trioxide in adult cancer patients with renal impairment

C. Takimoto, S. Remick, C. Sweeney, 2010, Cancer Chemotherapy and Pharmacology.

Oncology outpatient and provider responses to a computerized symptom assessment system.

Janet S Carpenter, David A Potter, J. Carpenter, 2008, Oncology nursing forum.

A Phase I and Pharmacokinetic Trial of Erlotinib in Combination with Weekly Docetaxel in Patients with Taxane-Naive Malignancies

Menggang Yu, A. Al Omari, C. Sweeney, 2008, Clinical Cancer Research.

A Phase I and Pharmacokinetic Trial of Erlotinib in Combination with Weekly Docetaxel in Patients with Taxane-Naive Malignancies

Menggang Yu, C. Sweeney, E. Chiorean, 2008, Clinical Cancer Research.